# Levofloxacin Versus Clarithromycin Triple Therapy in First-Line Treatment for Helicobacter Pylori Eradication

> **NCT00816140** · PHASE4 · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 432 (actual)

## Conditions studied

- Helicobacter Infections

## Interventions

- **DRUG:** Cravit based triple therapy
- **DRUG:** Klaricid based triple therapy

## Key facts

- **NCT ID:** NCT00816140
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 432 (ACTUAL)
- **Last updated:** 2011-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00816140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00816140, "Levofloxacin Versus Clarithromycin Triple Therapy in First-Line Treatment for Helicobacter Pylori Eradication". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00816140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*